Published in Aliment Pharmacol Ther on February 01, 2005
Clinical practice. Gastroesophageal reflux disease. N Engl J Med (2008) 3.30
Treating common problems of the nose and throat in pregnancy: what is safe? Eur Arch Otorhinolaryngol (2008) 1.52
Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol (2008) 1.49
Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci (2011) 1.43
Treatment of nausea and vomiting in pregnancy: an updated algorithm. Can Fam Physician (2007) 1.29
Omeprazole stimulates the induction of human insulin-like growth factor binding protein-1 through aryl hydrocarbon receptor activation. J Pharmacol Exp Ther (2007) 1.08
The safety of fetal exposure to proton-pump inhibitors during pregnancy. Dig Dis Sci (2011) 0.93
The effect of Acid-reducing pharmacotherapy on the severity of nausea and vomiting of pregnancy. Obstet Gynecol Int (2009) 0.86
Interventions for heartburn in pregnancy. Cochrane Database Syst Rev (2008) 0.84
Helicobacter pylori Infection Is Associated with an Increased Risk of Hyperemesis Gravidarum: A Meta-Analysis. Gastroenterol Res Pract (2015) 0.82
Use of proton pump inhibitors during pregnancy and breastfeeding. Can Fam Physician (2006) 0.81
Treating common ear problems in pregnancy: what is safe? Eur Arch Otorhinolaryngol (2007) 0.75
Comparison of two modes of stress measurement: daily hassles and uplifts versus major life events. J Behav Med (1981) 4.03
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene (1992) 3.48
Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med (1995) 2.75
The health-related functions of social support. J Behav Med (1981) 2.48
Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS (1996) 2.41
Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011. Ultrasound Obstet Gynecol (2012) 2.38
Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res (2001) 2.32
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. BJOG (2012) 2.14
High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study. Teratology (1999) 2.12
Evaluation of prenatal ultrasound diagnosis of fetal abdominal wall defects by 19 European registries. Ultrasound Obstet Gynecol (2001) 2.10
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. Arch Intern Med (1997) 1.92
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol (1992) 1.85
A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen. Br J Cancer (2006) 1.85
Playground equipment injuries in a large, urban school district. Am J Public Health (1984) 1.80
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J Virol (1992) 1.80
Identification and intracellular location of MAGE-3 gene product. Cancer Res (1995) 1.77
Human recombinant interleukin 1 beta has no effect on intracellular calcium or on functional responses of human neutrophils. J Immunol (1987) 1.75
Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology (2000) 1.64
Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease. Neurology (2007) 1.61
Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet (2001) 1.61
A prospective study of spontaneous abortion: relation to amount and source of drinking water consumed in early pregnancy. Epidemiology (1998) 1.54
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study. Ann Oncol (2007) 1.52
Recurrent tetraamelia and pulmonary hypoplasia with multiple malformations in sibs. Am J Med Genet (1991) 1.52
Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series. Eur J Neurol (2012) 1.51
Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol (1999) 1.50
Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A (2009) 1.49
Prenatal detection of congenital renal malformations by fetal ultrasonographic examination: an analysis of 709,030 births in 12 European countries. Eur J Med Genet (2005) 1.45
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
How wide is the clinical spectrum of the acrocallosal syndrome? Report of a mild case. J Med Genet (1990) 1.44
Effects of residential distance to hospitals with neonatal surgery care on prenatal management and outcome of pregnancies with severe fetal malformations. Ultrasound Obstet Gynecol (2007) 1.44
24, 25-dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation. Nature (1978) 1.44
Thomas syndrome: potter sequence with cleft lip/palate and cardiac anomalies. Am J Med Genet (1996) 1.43
Diabetes teratogenicity in mice is accompanied with distorted expression of TGF-beta2 in the uterus. Teratog Carcinog Mutagen (2002) 1.42
Moderate maternal alcohol consumption and risk of spontaneous abortion. Epidemiology (1997) 1.42
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Blood (1997) 1.41
Clinical teratology counseling and consultation case report: outcome of pregnancy after failure of early induced abortions. Teratology (1995) 1.38
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. Hum Mol Genet (2000) 1.38
Integrin alpha2beta1 plays a critical role in osteoblast response to micron-scale surface structure and surface energy of titanium substrates. Proc Natl Acad Sci U S A (2008) 1.37
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS (1997) 1.32
Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med (1998) 1.28
An inherited translocation t(4;15) (p16;q22) leading to two cases of partial trisomy 15. Ann Genet (1975) 1.28
A brain imaging (single photon emission computerized tomography) study of semantic and affective processing in psychopaths. Biol Psychiatry (1997) 1.27
The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol (2002) 1.27
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. J Virol (1996) 1.27
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. J Med Virol (1991) 1.26
Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet (2004) 1.25
Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol (2001) 1.25
The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. Endocr Relat Cancer (2000) 1.22
Life event questionnaires for measuring presumptive stress. Psychosom Med (1978) 1.22
Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology (1998) 1.21
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19
Spectrum of clinical variability in familial deletion 22q11.2: from full manifestation to extremely mild clinical anomalies. Clin Genet (2003) 1.18
Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult Scler (2009) 1.18
Evaluation of the prenatal diagnosis of limb reduction deficiencies. EUROSCAN Study Group. Prenat Diagn (2000) 1.17
Burden of spinal cord injury-related neuropathic pain in the United States: retrospective chart review and cross-sectional survey. Spinal Cord (2013) 1.17
Adverse effects of prenatal methimazole exposure. Teratology (2001) 1.17
Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update (2001) 1.16
Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds. J Clin Microbiol (1995) 1.16
Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology (1997) 1.15
Iron and the exclusively breast-fed infant from birth to six months. J Pediatr Gastroenterol Nutr (1985) 1.14
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum (2007) 1.14
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement. Med Oncol (2011) 1.14
Evolution of hypervariable region 1 of hepatitis C virus in primary infection. J Virol (1998) 1.13
Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions. Hum Mutat (1999) 1.13
Occupational exposure to organic solvent mixtures during pregnancy and the risk of non-syndromic oral clefts. Occup Environ Med (2006) 1.13
Risk of congenital anomalies in the vicinity of municipal solid waste incinerators. Occup Environ Med (2004) 1.13
Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology (2001) 1.13
Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol (1994) 1.12
Omphalocele and gastroschisis: a collaborative study of five Italian congenital malformation registries. Teratology (1993) 1.11
Prenatal detection and outcome of congenital diaphragmatic hernia: a French registry-based study. Ultrasound Obstet Gynecol (2007) 1.11
Placental findings in spontaneous abortions and stillbirths. Teratology (1981) 1.10
NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am J Hum Genet (2000) 1.09
Fibrochondrogenesis: radiologic and histologic studies. Am J Med Genet (1984) 1.08
Preoperative embolization in surgical treatment of mediastinal hemangiopericytoma. Ann Thorac Surg (2000) 1.08
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. Virology (2001) 1.08
Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells. J Biol Chem (1997) 1.08
Maternal endotoxemia, fetal anomalies, and central nervous system damage: a rat model of a human problem. Am J Obstet Gynecol (1976) 1.07
Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology (1999) 1.07
Congenital cytomegalovirus infection: a long-standing problem still seeking a solution. Am J Obstet Gynecol (1996) 1.07
Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS). Eur J Obstet Gynecol Reprod Biol (1996) 1.06
Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. Virology (1993) 1.04
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J Virol (1994) 1.04
Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. J Virol (1999) 1.04
Mortality of plastic-ware workers exposed to radiofrequencies. Bioelectromagnetics (1997) 1.04
Update of the follow-up of mortality and cancer incidence among European workers employed in the vinyl chloride industry. Epidemiology (2001) 1.03
Evaluation of the prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe. J Med Screen (2000) 1.03
Diverse prevalence of large deletions within the OA1 gene in ocular albinism type 1 patients from Europe and North America. Hum Genet (2001) 1.03
Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection. Virology (1999) 1.03
Achondrogenesis II-hypochondrogenesis: variability versus heterogeneity. Am J Med Genet (1986) 1.03
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res (2002) 1.02
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. Hepatology (1997) 1.02